PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1629135
PUBLISHER: Prescient & Strategic Intelligence | PRODUCT CODE: 1629135
U.S. Value-Based Healthcare Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2024 - 2030)
The U.S. value-based healthcare market is projected to grow from $3,810.0 billion in 2024 to $5,947.5 billion by 2030, registering a compound annual growth rate (CAGR) of 7.7%. This growth is driven by increasing efforts to reduce healthcare costs while improving patient outcomes. The adoption of advanced technologies, such as artificial intelligence (AI) and data analytics, is facilitating efficient care delivery and enhancing data-driven decision-making. Additionally, the rising prevalence of chronic diseases and a focus on coordinated, patient-centric care are propelling the market forward, supported by favorable regulatory policies.
Key Insights
The adoption of AI and data analytics is transforming care delivery by enabling real-time monitoring, predictive insights, and efficient care management.
Widespread use of electronic health records (EHRs) ensures seamless access to accurate patient data, supporting performance measurement and care quality improvement.
Value-based payment models are gaining traction, prioritizing outcome-based reimbursements to improve patient satisfaction and reduce costs.
Rising cases of chronic diseases are increasing the need for coordinated care, which is essential for effective treatment and cost containment.
Big data integration allows healthcare providers to identify high-risk patients, track the effectiveness of care initiatives, and improve population health management.
Government policies and regulations are fostering the adoption of value-based care, creating a conducive environment for its implementation.
Patient-centric approaches, focusing on improving satisfaction and outcomes, are becoming central to value-based healthcare models.
Cost containment remains a key objective, as value-based models aim to deliver efficient, high-quality care while reducing unnecessary expenditures.
Continuous quality improvement efforts are essential in ensuring better healthcare services and enhancing patient outcomes.
Efforts to address healthcare inequities and improve access to quality care are critical to promoting equity within value-based care frameworks.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by deployment
- 1.4.2. Market size breakdown, by model
- 1.4.3. Market size breakdown, by end user
- 1.4.4. Market size breakdown, by region
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. U.S. Market
- 6.1. Overview
- 6.2. Market Revenue, by Deployment (2019-2030)
- 6.3. Market Revenue, by Model (2019-2030)
- 6.4. Market Revenue, by End User (2019-2030)
- 6.5. Market Revenue, by Region (2019-2030)
Chapter 7. Competitive Landscape
- 7.1. List of Market Players and their Offerings
- 7.2. Competitive Benchmarking of Key Players
- 7.3. Product Benchmarking of Key Players
- 7.4. Recent Strategic Developments
Chapter 8. Company Profiles
- 8.1. Koninklijke Philips N.V.
- 8.1.1. Business overview
- 8.1.2. Product and service offerings
- 8.1.3. Key financial summary
- 8.2. Air Liquide S.A.
- 8.2.1. Business overview
- 8.2.2. Product and service offerings
- 8.2.3. Key financial summary
- 8.3. Amedisys Inc.
- 8.3.1. Business overview
- 8.3.2. Product and service offerings
- 8.3.3. Key financial summary
- 8.4. Atropos Health Inc.
- 8.4.1. Business overview
- 8.4.2. Product and service offerings
- 8.4.3. Key financial summary
- 8.5. Arcadia Solutions LLC
- 8.5.1. Business overview
- 8.5.2. Product and service offerings
- 8.5.3. Key financial summary
- 8.6. DaVita Inc.
- 8.6.1. Business overview
- 8.6.2. Product and service offerings
- 8.6.3. Key financial summary
- 8.7. CVS Health Corporation
- 8.7.1. Business overview
- 8.7.2. Product and service offerings
- 8.7.3. Key financial summary
- 8.8. BAYADA Home Health Care
- 8.8.1. Business overview
- 8.8.2. Product and service offerings
- 8.8.3. Key financial summary
- 8.9. Conifer Health Solutions LLC
- 8.9.1. Business overview
- 8.9.2. Product and service offerings
- 8.9.3. Key financial summary
- 8.10. Knight Health Holdings LLC
- 8.10.1. Business overview
- 8.10.2. Product and service offerings
- 8.10.3. Key financial summary
- 8.11. LHC Group Inc.
- 8.11.1. Business overview
- 8.11.2. Product and service offerings
- 8.11.3. Key financial summary
- 8.12. Boston Consulting Group Inc.
- 8.12.1. Business overview
- 8.12.2. Product and service offerings
- 8.12.3. Key financial summary
Chapter 9. Appendix
- 9.1. Abbreviations
- 9.2. Sources and References
- 9.3. Related Reports
